ABBV-RGX-314 Gene Therapy Reduces nAMD Injections in Bilateral Study
In a major advancement for treating neovascular age-related macular degeneration (nAMD), the investigational gene therapy ABBV-RGX-314 of Regenxbio…
Browsing Tag